News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
790,865 Results
Type
Article (56273)
Company Profile (373)
Press Release (734197)
Multimedia
Podcasts (156)
Webinars (27)
Section
Business (219419)
Career Advice (2905)
Deals (37951)
Drug Delivery (155)
Drug Development (87532)
Employer Resources (186)
FDA (17665)
Job Trends (16294)
News (373503)
Policy (36411)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2950)
Academic (1)
Accelerated approval (45)
Adcomms (36)
Allergies (175)
Alliances (53826)
ALS (208)
Alzheimer's disease (1872)
Antibody-drug conjugate (ADC) (426)
Approvals (17920)
Artificial intelligence (680)
Autoimmune disease (245)
Automation (52)
Bankruptcy (390)
Best Places to Work (12267)
BIOSECURE Act (21)
Biosimilars (220)
Biotechnology (233)
Bladder cancer (186)
Brain cancer (72)
Breast cancer (729)
Cancer (5714)
Cardiovascular disease (494)
Career advice (2466)
Career pathing (46)
CAR-T (329)
CDC (66)
Celiac Disease (2)
Cell therapy (879)
Cervical cancer (45)
Clinical research (75036)
Collaboration (2093)
Company closure (5)
Compensation (1313)
Complete response letters (92)
COVID-19 (2954)
CRISPR (110)
C-suite (1082)
Cystic fibrosis (157)
Data (7325)
Decentralized trials (3)
Denatured (46)
Depression (174)
Dermatology (67)
Diabetes (581)
Diagnostics (7239)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (331)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (285)
Earnings (94572)
Editorial (72)
Employer branding (23)
Employer resources (164)
Events (127489)
Executive appointments (1115)
FDA (21237)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1715)
Gene editing (234)
Generative AI (65)
Gene therapy (726)
GLP-1 (1164)
Government (5243)
Grass and pollen (8)
Guidances (403)
Healthcare (20333)
HIV (80)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (320)
Immuno-oncology (96)
Indications (164)
Infectious disease (3299)
Inflammatory bowel disease (220)
Inflation Reduction Act (15)
Influenza (137)
Intellectual property (285)
Interviews (559)
IPO (17311)
IRA (59)
Job creations (4359)
Job search strategy (2003)
JPM (71)
Kidney cancer (20)
Labor market (94)
Layoffs (642)
Leadership (46)
Legal (9032)
Liver cancer (106)
Longevity (29)
Lung cancer (763)
Lymphoma (419)
Machine learning (56)
Management (64)
Manufacturing (998)
MASH (195)
Medical device (14557)
Medtech (14641)
Mergers & acquisitions (21816)
Metabolic disorders (1552)
mRNA (207)
Multiple sclerosis (185)
NASH (24)
Neurodegenerative disease (425)
Neuropsychiatric disorders (114)
Neuroscience (3392)
Neurotech (1)
NextGen: Class of 2026 (7191)
Non-profit (4952)
Now hiring (74)
Obesity (747)
Opinion (342)
Ovarian cancer (201)
Pain (253)
Pancreatic cancer (275)
Parkinson's disease (366)
Partnered (34)
Patents (585)
Patient recruitment (639)
Peanut (65)
People (64799)
Pharmaceutical (90)
Pharmacy benefit managers (34)
Phase 1 (23274)
Phase 2 (32857)
Phase 3 (24645)
Pipeline (7531)
Policy (357)
Postmarket research (2988)
Preclinical (9948)
Press Release (71)
Prostate cancer (291)
Psychedelics (60)
Radiopharmaceuticals (326)
Rare diseases (1103)
Real estate (6650)
Recruiting (77)
Regulatory (27461)
Reports (55)
Research institute (2673)
Resumes & cover letters (458)
Rett syndrome (34)
RNA editing (21)
RSV (92)
Schizophrenia (180)
Series A (288)
Series B (214)
Service/supplier (13)
Sickle cell disease (115)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (3994)
State (2)
Stomach cancer (21)
Supply chain (134)
Tariffs (102)
The Weekly (107)
Vaccines (1187)
Venture capital (108)
Weight loss (500)
Women's health (115)
Worklife (22)
Date
Today (143)
Last 7 days (551)
Last 30 days (2656)
Last 365 days (31569)
2026 (9144)
2025 (31768)
2024 (36959)
2023 (41888)
2022 (53138)
2021 (57812)
2020 (56651)
2019 (49913)
2018 (37816)
2017 (34846)
2016 (34865)
2015 (40888)
2014 (35010)
2013 (30361)
2012 (32344)
2011 (32974)
2010 (31148)
Location
Africa (970)
Alabama (99)
Alaska (7)
Arizona (349)
Arkansas (16)
Asia (45904)
Australia (8072)
California (12682)
Canada (3615)
China (1336)
Colorado (541)
Connecticut (543)
Delaware (382)
Europe (101502)
Florida (1902)
Georgia (410)
Hawaii (3)
Idaho (66)
Illinois (1049)
India (89)
Indiana (588)
Iowa (23)
Japan (515)
Kansas (134)
Kentucky (48)
Louisiana (40)
Maine (75)
Maryland (1551)
Massachusetts (9193)
Michigan (360)
Minnesota (714)
Mississippi (7)
Missouri (152)
Montana (36)
Nebraska (29)
Nevada (140)
New Hampshire (87)
New Jersey (3368)
New Mexico (31)
New York (3366)
North Carolina (1690)
North Dakota (9)
Northern California (6256)
Ohio (383)
Oklahoma (25)
Oregon (47)
Pennsylvania (2563)
Puerto Rico (29)
Rhode Island (52)
South America (1350)
South Carolina (82)
South Dakota (2)
Southern California (4981)
Tennessee (203)
Texas (2019)
United States (45335)
Utah (382)
Vermont (1)
Virginia (317)
Washington D.C. (86)
Washington State (1038)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
790,865 Results for "aveo oncology formerly known as aveo pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AVEO Oncology, an LG Chem company, Announces Completion of the First Interim Analysis in the Global Phase 3 FIERCE-HN Study
February 18, 2026
·
6 min read
Press Releases
AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab
January 15, 2026
·
5 min read
Press Releases
AVEO Oncology, an LG Chem company, and HiberCell Enter Into an Exclusive Development and Option Agreement for First-in-Human Compound
November 5, 2025
·
9 min read
Press Releases
AVEO Oncology, an LG Chem company, Presents Three Posters at ASCO 2025 Annual Meeting
June 3, 2025
·
9 min read
Business
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
AVEO Oncology (“AVEO”), an LG Chem company, today announced the appointment of Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer.
March 25, 2024
·
5 min read
Press Releases
AVEO Oncology, an LG Chem company, Announces Three Poster Presentations at ASCO 2025 Annual Meeting
April 29, 2025
·
3 min read
Kidney Cancer
AVEO’s Fotivda Combo Flunks Phase III Renal Cell Carcinoma Study
While its investigational regimen fell short of the primary efficacy endpoint, AVEO dug into data from its control group and touted a “clinically meaningful” improvement in progression-free survival in patients receiving Fotivda monotherapy.
July 19, 2024
·
2 min read
·
Tristan Manalac
Press Releases
AVEO Oncology, an LG Chem company, Presents Two Posters for Tivozanib at the 2025 ASCO GU Meeting
February 19, 2025
·
9 min read
Drug Development
LG Chem company and AVEO Oncology Announce LG Chem’s First Proprietary Anti-Cancer Compound enters Phase 1 Clinical Study, Dosing Initiated in the U.S.
LG Chem and AVEO Oncology, an LG Chem company, announced that it has enrolled the first patient in the United States for a Phase 1 clinical study of LB-LR1109, LG Chem’s first proprietary anti-cancer investigational drug candidate.
June 13, 2024
·
4 min read
Genetown
AVEO Oncology, an LG Chem company, Earns Spot on Boston Globe’s 2023 Top Places to Work List for Second Consecutive Year
For the second year in a row, AVEO Oncology, an LG Chem company, has earned a spot on the Boston Globe’s annual ‘Top Places to Work in Massachusetts’ list.
November 30, 2023
·
3 min read
1 of 79,087
Next
